januvia and glp 1 sitagliptin [TUSOM Januvia and Janumet Drug Interactions,

The STEP 2 trial, conducted in patients with type 2 diabetes, demonstrated even greater triglyceride reductions (averaging 20-25%), likely reflecting the baseline metabolic dysfunction in this population

HongS-JVogelsteinJTGozziABernhardtBCYeoBTTMilhamMPet al

In agreement with the expression profile of SP, it has been implicated in mood (Santarelli et al., 2001), stress (Papp et al., 2000), reward sensitivity (Thorsell et al., 2010), energy homeostasis (Karagiannides et al., 2008), pain (Hill, 2000), and learning (Huston and Hasenohrl, 1995)

Targeting cellular antioxidant enzymes for treating atherosclerotic vascular disease